These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31252)

  • 1. Comparative analysis of systemic immunological parameters in ulcerative colitis and idiopathic proctitis: effects of sulfasalazine in vivo and in vitro.
    Rubinstein A; Das KM; Melamed J; Murphy RA
    Clin Exp Immunol; 1978 Aug; 33(2):217-24. PubMed ID: 31252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance oral sulfasalazine prolongs remission in ulcerative proctitis and proctosigmoiditis.
    LaRosa D; Rubin PH; Bodian C; Present DH
    Am J Gastroenterol; 1991 Oct; 86(10):1456-60. PubMed ID: 1681725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rectal effect of salazopyrine in ulcerative colitis during a double-blind study].
    Schulz U; Hanke P; Seige K
    Wien Z Inn Med; 1973; 54(4):185-9. PubMed ID: 4148682
    [No Abstract]   [Full Text] [Related]  

  • 4. [Activation of nuclear factor-kappaB and effects of anti-inflammatory treatment thereon in intestinal mucosa of patients with ulcerative colitis].
    Gan H; Ouyang Q; Chen Y; Xia Q
    Zhonghua Yi Xue Za Zhi; 2002 Mar; 82(6):384-8. PubMed ID: 11953203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chloroquine for mild to moderately active ulcerative colitis: comparison with sulfasalazine.
    Goenka MK; Kochhar R; Tandia B; Mehta SK
    Am J Gastroenterol; 1996 May; 91(5):917-21. PubMed ID: 8633581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of the mucosa with local anaesthetics in ulcerative colitis.
    Björck S; Dahlström A; Johansson L; Ahlman H
    Agents Actions; 1992; Spec No():C60-72. PubMed ID: 1442337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating auto-antibody against hepatoma-derived growth factor (HDGF) in patients with ulcerative colitis.
    Nahamura H; Yoshida K; Kishima Y; Enomoto H; Uyama H; Kuroda T; Okuda Y; Hirotani T; Ito H; Kawase I
    Hepatogastroenterology; 2004; 51(56):470-5. PubMed ID: 15086185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the Kp43 (CD 94) receptor by natural killer (NK) cells in ulcerative colitis.
    del Mar Cabrera M; Valle J; Pajares JM; Romero I; Zomeño M; Maté J
    Hepatogastroenterology; 2001; 48(41):1316-20. PubMed ID: 11677954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the efficacy of ready-made-up commercially available salicylazosulphapyridine enemas in the treatment of proctitis, proctosigmoiditis and ulcerative colitis involving rectum, sigmoid and descending colon.
    Frühmorgen P; Demling L
    Hepatogastroenterology; 1980 Dec; 27(6):473-6. PubMed ID: 6110627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug therapy: Sulfasalazine.
    Goldman P; Peppercorn MA
    N Engl J Med; 1975 Jul; 293(1):20-3. PubMed ID: 236516
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sulfasalazine enema in acute left-sided ulcerative colitis (author's transl)].
    Frimberger E; Frühmorgen P; Kühner W; Ottenjann R
    MMW Munch Med Wochenschr; 1980 Sep; 122(36):1233-5. PubMed ID: 6108506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Course and natural history of idiopathic ulcerative proctitis in adults].
    Ghirardi M; Nascimbeni R; Mariani PP; Di Fabio F; Salerni B
    Ann Ital Chir; 2002; 73(2):155-8; discussion 158-9. PubMed ID: 12197289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil and eosinophil granule proteins as markers of response to local prednisolone treatment in distal ulcerative colitis and proctitis.
    Sangfelt P; Carlson M; Thörn M; Lööf L; Raab Y
    Am J Gastroenterol; 2001 Apr; 96(4):1085-90. PubMed ID: 11316151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of long-term therapy with sulphasalazine, levamisole, corticosteroids and ascorbic acid and of disease activity on polymorphonuclear leukocyte function in patients with ulcerative colitis.
    Hermanowicz A; Sliwiński Z; Kaczor R
    Hepatogastroenterology; 1985 Apr; 32(2):81-6. PubMed ID: 2861152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of BX661A, a new therapeutic agent for ulcerative colitis, on chemotaxis and reactive oxygen species production in polymorphonuclear leukocytes in comparison with salazosulfapyridine and its metabolite sulfapyridine.
    Kimura I; Kawasaki M; Matsuda A; Kataoka M; Kokurba Y
    Arzneimittelforschung; 1998 Dec; 48(12):1163-7. PubMed ID: 9893931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.
    Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral immune system and ulcerative colitis activity. I. Serum immunoglobulins and C-reactive protein levels.
    Hermanowicz A; Sliwiński Z; Nawarska Z
    Arch Immunol Ther Exp (Warsz); 1984; 32(5):501-8. PubMed ID: 6152529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell immunoregulation in patients with inflammatory bowel disease. II. Enhanced suppressor T-cell activity in ulcerative colitis.
    Kramer JK; Depew WT; Szewczuk MR
    J Clin Lab Immunol; 1988 Jan; 25(1):19-27. PubMed ID: 2968458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration in T lymphocyte subpopulations in inflammatory bowel disease.
    Victorino RM; Hodgson HJ
    Clin Exp Immunol; 1980 Jul; 41(1):156-65. PubMed ID: 6969150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.